Table 2 Hazard ratios (HRs) for death and recurrence with 95% confidence intervals (CIs) according to partner's vital status among 21 213 women with breast cancer diagnosed in 1994–2006, Denmark

From: Loss of partner and breast cancer prognosis — a population-based study, Denmark, 1994–2010

    

Crude a

Adjusted HR b

Adjusted HR c

 

N

Person years

Events

HR

(95% CI)

HR

(95% CI)

HR

(95% CI)

All-cause mortality

 Partner alive at exit (ref.)

18 192

144 410

4977

1.00

 

1.00

 

1.00

 

 Exposed in the 4 years before diagnosis

762

5216

243

1.14

(1.00, 1.30)

1.07

(0.94, 1.22)

1.10

(0.95, 1.27)

 Exposed 0–17 years after diagnosis

2259

23 147

440

1.12

(1.01, 1.25)

1.09

(0.98, 1.20)

1.09

(0.98, 1.22)

Recurrence

 Partner alive at exit (ref.)

19 312

86 453

2635

1.00

 

1.00

 

1.00

 

 Exposed in the 4 years before diagnosis

762

2839

59

0.83

(0.64, 1.08)

0.82

(0.63, 1.06)

0.82

(0.61, 1.09)

 Exposed 0–17 years after diagnosis

1139

7581

85

0.98

(0.78, 1.22)

0.97

(0.78, 1.21)

0.93

(0.73, 1.18)

  1. aStratified by age at diagnosis in 1-year intervals.
  2. bAdjusted for the highest-attained educational level, disposable income, and stratified by age at diagnosis in 1-year intervals (defined in Table 1).
  3. cAdjusted for the highest-attained educational level, disposable income, period of diagnosis, comorbidity, tumour size, no. of tumour-positive lymph-nodes, hormone receptor status, malignancy grade and stratified by age at diagnosis in 1-year intervals (N=19 186) (defined in Table 1).